News

The latest SV company and portfolio news.

8 October 2024
Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
11 September 2024
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
12 August 2024
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
6 August 2024
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
24 July 2024
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
24 June 2024
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
29 May 2024
Merck signs $3bn deal for Kate Bingham-backed eye disease biotechRead More
29 May 2024
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
21 May 2024
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
4 March 2024
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
11 January 2024
SV investment has resulted in the approval of 24 novel therapeutics
4 January 2024
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
13 December 2023
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
21 November 2023
Merck to Acquire Caraway Therapeutics, Inc.
14 November 2023
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
8 November 2023
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group

SV News


Investing in Women Code Logo
PROUD SIGNATORIES

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.